Revealing the high propensity of RNAs to non-specifically bind drug-like small molecules
Preprint
Abstract
Identifying small molecules that selectively bind a single RNA target while discriminating against all other cellular RNAs is an important challenge in RNA-targeted drug discovery. Much effort has been directed toward identifying drug-like small molecules that minimize electrostatic and stacking interactions that lead to non-specific binding of aminoglycosides and intercalators to a variety of RNAs. Many such compounds have been reported to bind RNAs and inhibit their cellular activities, however the ability of such compounds to discriminate against RNA stem-loops commonly found in the transcriptome has not been thoroughly assessed in all cases. Here, we examined the propensities of three drug-like compounds, previously shown to bind and inhibit the cellular activity of three distinct RNAs, to non-specifically bind two HIV-1 stem-loop RNAs: the transactivation response element (TAR) and stem IIB in the rev response element (RREIIB). All three compounds bound to TAR and RREIIB in vitro , and two inhibited TAR-dependent transactivation and RRE-dependent viral export in cell-based assays while also exhibiting substantial off-target interactions consistent with non-specific cellular activity. A survey of X-ray and NMR structures of RNA-small molecule complexes revealed that drug-like molecules form hydrogen bonds with functional groups commonly accessible in canonical stem-loop RNA motifs, much like aminoglycosides, and in contrast to ligands that specifically bind riboswitches. Our results support extending the group of non-selective RNA-binders beyond aminoglycosides and intercalators to encompass drug-like compounds with capacity for non-specific hydrogen-bonding and reinforce the importance of assaying for off-target interactions and RNA selectivity in vitro and in cells when assessing novel RNA-binders.Keywords
All Related Versions
- Published version: RNA, 27 (1), 12.
This publication has 107 references indexed in Scilit:
- Structure of a hepatitis C virus RNA domain in complex with a translation inhibitor reveals a binding mode reminiscent of riboswitchesProceedings of the National Academy of Sciences, 2012
- New developments in aminoglycoside therapy and ototoxicityHearing Research, 2011
- Discovery of selective bioactive small molecules by targeting an RNA dynamic ensembleNature Chemical Biology, 2011
- Illuminating Insights into Firefly Luciferase and Other Bioluminescent Reporters Used in Chemical BiologyChemistry & Biology, 2010
- Pentamidine reverses the splicing defects associated with myotonic dystrophyProceedings of the National Academy of Sciences, 2009
- Conformational inhibition of the hepatitis C virus internal ribosome entry site RNANature Chemical Biology, 2009
- How binding of small molecule and peptide ligands to HIV-1 TAR alters the RNA motional landscapeNucleic Acids Research, 2009
- The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB dataNucleic Acids Research, 2006
- Rational Design of Inhibitors of HIV-1 TAR RNA through the Stabilisation of Electrostatic “Hot Spots”Journal of Molecular Biology, 2004
- NMRPipe: A multidimensional spectral processing system based on UNIX pipesJournal of Biomolecular NMR, 1995